Page 2 - Ed Arce News Today

Akebia Therapeutics (AKBA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ed Arce...

Goldman Sachs increased the price target for Constellation Brands, Inc. (NYSE: STZ) from $275 to $305. Goldman Sachs analyst Bonnie Herzog maintained a Buy rating. Constellation shares fell 0.8% to $254.00 in pre-market trading.

In a report released today, Ed Arce from H.C. Wainwright maintained a Hold rating on Axcella Health (AXLA – Research Report). The company&...

Operator: Good day and welcome to Akebias Second Quarter 2023 Financial Results Call. At this time, all participants are in a listen-only mode.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on CVS Health (CVS – Research Report) and Iterum...

Operator: Welcome to the AcelRx Second Quarter 2023 Financial Results Conference Call.

Operator: Good afternoon, and thank you all for joining. I would like to welcome you all to the Mirum Pharmaceuticals Report Second Quarter 2023 Financial Results and Provide Business Update.

Operator: Greetings, and welcome to the DURECT Corporation Second Quarter Earnings Call. [Operator Instructions]. It is now my pleasure to introduce your host, Tim Papp, Chief Financial Officer.

Operator: Hello, and thank you for standing by. Welcome to Intercept Pharmaceuticals Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Operator: Greetings. And welcome to Aurinia Pharmaceuticals Incorporated Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.